Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1027 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Aurobindo, OJSC Diod form JV in Russia

The new JV – Aurospharma – intends to construct a plant to manufacture non penicillin and non cephalosporin Rx generics and other drugs that are categorized as over

Dynavax gets SBIR grant

The grant of $600,000 is expected to support the research to characterize the role of the phosphoinositide 3-kinase (PI3K) in preclinical models of skin autoimmune inflammation. Dynavax vice

iPierian designates Nancy Stagliano as CEO

Stagliano, recently served as the CEO and co-founder of CytomX Therapeutics, will succeed interim CEO Peter Van Vlasselear. Earlier, she worked as the COO of CytomX, which launched

Teva UK rolls out Levetiracetam tablets

Teva’s Levetiracetam tablets are the generic version of UCB Pharma’s Keppra (levetiracetam). The drug is available in 250, 500, 750 and 1,000mg film-coated tablets in the market. Levetiracetam